semaglutide and eye problems Ozempic Face: What causes it how to prevent it? Ophthalmologic Manifestations from Semaglutide (Ozempic/Wegovy)

Nov 1: Mercks blockbuster Keytruda racked up another FDA approval Wednesday, as the company announced that the anti-PD-1 therapy is now authorizedin combination with gemcitabine and cisplatinto treat patients with locally advanced unresectable or metastatic biliary tract cancer (BTC)

Although their proposed GLP1-based pill had to be scrapped earlier this year following evidence of liver toxicity in a Phase III trial 12 , Pfizer has recently acquired Metasera, a biopharmaceutical company specialising in obesity therapeutics

The Binge Cycle Struggler: Those facing patterns of overeating, excessive appetite, and difficulty maintaining consistent eating habits

This study was sponsored by Pfizer Inc